These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

923 related items for PubMed ID: 26229096

  • 1. Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study.
    Moreno-Arribas J, Bertomeu-González V, Anguita-Sanchez M, Cequier Á, Muñiz J, Castillo J, Sanchis J, Roldán I, Marín F, Bertomeu-Martínez V, investigators of the FANTASIIA study.
    J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):150-6. PubMed ID: 26229096
    [Abstract] [Full Text] [Related]

  • 2. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV, Ma CS, Diener HC, Dubner SJ, Halperin JL, Rothman KJ, Teutsch C, Schoof N, Kleine E, Bartels DB, Lip GY, GLORIA-AF Investigators.
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [Abstract] [Full Text] [Related]

  • 3. Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends.
    Shiyovich A, Shalev V, Chodick G, Tirosh M, Katz A, Klar MM, Shuvy M, Pereg D, Minha S.
    BMC Cardiovasc Disord; 2021 Oct 13; 21(1):493. PubMed ID: 34645389
    [Abstract] [Full Text] [Related]

  • 4. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
    De Caterina R, Brüggenjürgen B, Darius H, Köhler S, Lucerna M, Pecen L, Renda G, Schilling RJ, Schliephacke T, Zamorano JL, Le Heuzey JY, Kirchhof P.
    Arch Cardiovasc Dis; 2018 Feb 13; 111(2):74-84. PubMed ID: 28942115
    [Abstract] [Full Text] [Related]

  • 5. Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry.
    Michalski F, Tittl L, Werth S, Hänsel U, Pannach S, Sahin K, Weiss N, Beyer-Westendorf J.
    Thromb Haemost; 2015 Nov 13; 114(5):1076-84. PubMed ID: 25994496
    [Abstract] [Full Text] [Related]

  • 6. New oral anticoagulants for the prevention of thromboembolic complications in atrial fibrillation: a single centre experience.
    Gorczyca-Michta I, Wożakowska-Kapłon B.
    Kardiol Pol; 2015 Nov 13; 73(2):85-93. PubMed ID: 25179482
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group.
    Pharithi RB, Ranganathan D, O'Brien J, Egom EE, Burke C, Ryan D, McAuliffe C, Vaughan M, Coughlan T, Morrissey E, McHugh J, Moore D, Collins R.
    Ir J Med Sci; 2019 Feb 13; 188(1):101-108. PubMed ID: 29860595
    [Abstract] [Full Text] [Related]

  • 9. Treatment Changes among Users of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation.
    Hellfritzsch M, Husted SE, Grove EL, Rasmussen L, Poulsen BK, Johnsen SP, Hallas J, Pottegård A.
    Basic Clin Pharmacol Toxicol; 2017 Feb 13; 120(2):187-194. PubMed ID: 27580086
    [Abstract] [Full Text] [Related]

  • 10. Thromboembolic and bleeding complications during oral anticoagulation therapy in cancer patients with atrial fibrillation: a Danish nationwide population-based cohort study.
    Ording AG, Horváth-Puhó E, Adelborg K, Pedersen L, Prandoni P, Sørensen HT.
    Cancer Med; 2017 Jun 13; 6(6):1165-1172. PubMed ID: 28544489
    [Abstract] [Full Text] [Related]

  • 11. Utilization of oral anticoagulants in Korean nonvalvular atrial fibrillation patients.
    Song HY, Son KB, Shin JY, Bae S.
    Int J Clin Pharm; 2019 Dec 13; 41(6):1434-1441. PubMed ID: 31522377
    [Abstract] [Full Text] [Related]

  • 12. Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists.
    Konieczyńska M, Sobieraj E, Bryk AH, Dębski M, Polak M, Podolec P, Małecka B, Pająk A, Desteghe L, Heidbuchel H, Undas A.
    Kardiol Pol; 2018 Dec 13; 76(7):1089-1096. PubMed ID: 29528483
    [Abstract] [Full Text] [Related]

  • 13. Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.
    Pastori D, Lip GYH, Farcomeni A, Del Sole F, Sciacqua A, Perticone F, Marcucci R, Grifoni E, Pignatelli P, Violi F, ATHERO-AF study group.
    Int J Cardiol; 2018 Aug 01; 264():58-63. PubMed ID: 29776574
    [Abstract] [Full Text] [Related]

  • 14. Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation.
    Patti G, Pecen L, Lucerna M, Huber K, Rohla M, Renda G, Siller-Matula J, Ricci F, Kirchhof P, De Caterina R.
    Am J Med; 2019 Jun 01; 132(6):749-757.e5. PubMed ID: 30664837
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort study.
    Denas G, Gennaro N, Ferroni E, Fedeli U, Saugo M, Zoppellaro G, Padayattil Jose S, Costa G, Corti MC, Andretta M, Pengo V.
    Int J Cardiol; 2017 Dec 15; 249():198-203. PubMed ID: 28935464
    [Abstract] [Full Text] [Related]

  • 16. Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.
    Joosten LPT, van Doorn S, Hoes AW, Nierman MC, Wiersma NM, Koek HL, Hemels MEW, Huisman MV, Roes KC, van den Bor RM, Buding WF, Rutten FH, Geersing GJ.
    BMJ Open; 2019 Dec 29; 9(12):e032488. PubMed ID: 31888928
    [Abstract] [Full Text] [Related]

  • 17. Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study.
    Staerk L, Fosbøl EL, Lamberts M, Bonde AN, Gadsbøll K, Sindet-Pedersen C, Holm EA, Gerds TA, Ozenne B, Lip GYH, Torp-Pedersen C, Gislason GH, Olesen JB.
    Eur Heart J; 2018 May 14; 39(19):1698-1705a. PubMed ID: 29165556
    [Abstract] [Full Text] [Related]

  • 18. Use and Outcomes of Triple Antithrombotic Therapy with Non-Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Casamira N, García-Camarero T, Montoro-Ronsano JB, Veiga G, Del Blanco BG, De La Torre JM, Gordon B, García-Dorado D, Sambola A.
    Am J Med Sci; 2019 Aug 14; 358(2):95-103. PubMed ID: 31176420
    [Abstract] [Full Text] [Related]

  • 19. Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.
    Seiffge DJ, Hooff RJ, Nolte CH, Béjot Y, Turc G, Ikenberg B, Berge E, Persike M, Dequatre-Ponchelle N, Strbian D, Pfeilschifter W, Zini A, Tveiten A, Næss H, Michel P, Sztajzel R, Luft A, Gensicke H, Traenka C, Hert L, Scheitz JF, De Marchis GM, Bonati LH, Peters N, Charidimou A, Werring DJ, Palm F, Reinhard M, Niesen WD, Nagao T, Pezzini A, Caso V, Nederkoorn PJ, Kägi G, von Hessling A, Padjen V, Cordonnier C, Erdur H, Lyrer PA, Brouns R, Steiner T, Tatlisumak T, Engelter ST, NOACISP Study Group*.
    Circulation; 2015 Sep 29; 132(13):1261-9. PubMed ID: 26232277
    [Abstract] [Full Text] [Related]

  • 20. Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic.
    Lee SI, Sayers M, Lip GY, Lane DA.
    Int J Clin Pract; 2015 Nov 29; 69(11):1341-8. PubMed ID: 26234557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.